(Q40181556)

18 September 2017

title

Long-term suppression of experimental arthritis following intramuscular administration of a pseudotyped AAV2/1-TNFR:Fc Vector (English)

1 reference

18 September 2017

Ziv Sandalon

1

1 reference

18 September 2017

Elizabeth M Bruckheimer

series ordinal

2

1 reference

18 September 2017

Kurt H Lustig

series ordinal

3

1 reference

18 September 2017

Haim Burstein

series ordinal

4

1 reference

18 September 2017

publication date

1 February 2007

1 reference

18 September 2017

1 reference

18 September 2017

volume

15

1 reference

18 September 2017

issue

2

1 reference

18 September 2017

page(s)

264-269

1 reference

The tumor necrosis factor ligand and receptor families.

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Cytokine pathways and joint inflammation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Association between degree of bone-erosion and synovial fluid-levels of tumor necrosis factor alpha in the knee-joints of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Gene transfer into skeletal muscle using novel AAV serotypes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

New drugs for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Pharmacologic transgene control systems for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

A humanized system for pharmacologic control of gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Long-term regulated expression of growth hormone in mice after intramuscular gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Cloning of infectious adeno-associated virus genomes in bacterial plasmids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Nucleotide sequence and organization of the adeno-associated virus 2 genome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Reactivation of streptococcal cell wall-induced arthritis by homologous and heterologous cell wall polymers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300043

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300043

1 reference

18 September 2017

1 reference